Global Helicobacter Pylori Antigen Test Market Growth (Status and Outlook) 2023-2029
The global Helicobacter Pylori Antigen Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Helicobacter Pylori Antigen Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Helicobacter Pylori Antigen Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Helicobacter Pylori Antigen Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Helicobacter Pylori Antigen Test players cover Abbott Laboratories, Bio-Rad Laboratories, DiaSorin, Dynex Technologies, Eurofins Scientific, Grifols Diagnostic Solutions, Halyard Health, Meridian Bioscience and MP Biomedicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Helicobacter Pylori Antigen Test Industry Forecast” looks at past sales and reviews total world Helicobacter Pylori Antigen Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Antigen Test sales for 2023 through 2029. With Helicobacter Pylori Antigen Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Antigen Test industry.
This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Antigen Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Helicobacter Pylori Antigen Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helicobacter Pylori Antigen Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Antigen Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Antigen Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Antigen Test market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Rapid Diagnostic Test (RDT)
Enzyme-linked Immunosorbent Assay (ELISA)
Lateral Flow Immunoassay (LFIA)
Chemiluminescent Immunoassay (CLIA)
Segmentation by application
Healthcare Industry
Clinical Diagnostics Laboratories
Research and Academic Institutions
Pharmaceutical Industry
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Bio-Rad Laboratories
DiaSorin
Dynex Technologies
Eurofins Scientific
Grifols Diagnostic Solutions
Halyard Health
Meridian Bioscience
MP Biomedicals
Quidel Corporation
Roche Diagnostics
Sekisui Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Trinity Biotech
AlphaBiolabs
BIOTECON Diagnostics
Creative Diagnostics
Cypress Diagnostics
Diagnostic Automation/Cortez Diagnostics
DRG International
Humasis
Immunostics
Invivoscribe
SD Biosensor
Please note: The report will take approximately 2 business days to prepare and deliver.